Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma
- PMID: 15750198
- DOI: 10.1385/MO:22:1:063
Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma
Abstract
The present study evaluated the significance of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in 30 patients with endometrial carcinoma and the relationship of those molecular markers to tumor characteristics and microvessel density (MVD). Immunohistochemical expression of COX-2, iNOS, and CD34 was analyzed on paraffin-embedded tissue sections. The COX-2 and iNOS positive rates were 66.7% and 73.3%, respectively. The level of COX-2 expression was higher in grade II tumors than in grade III tumors (p < 0.05). The percentage of iNOS positivity was higher in patients with deep myometrial invasion than in patients without or less than 50% myometrial invasion (p < 0.05). There was significant correlation between positive COX-2 and positive iNOS expression (r = 0.601, p < 0.001). Both COX-2 and iNOS were significantly correlated with MVD (r = 0.02 p < 0.05; r = 0.599 p < 0.0001, respectively). The present findings suggest that combined expression of COX-2 and iNOS may play an important role in development and invasion of endometrial cancer and that this could be partially attributable to modulation of angiogenesis by COX-2 and iNOS.
Similar articles
-
Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.Clin Cancer Res. 2001 May;7(5):1325-32. Clin Cancer Res. 2001. PMID: 11350902
-
Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer.J Gastroenterol Hepatol. 2002 Aug;17(8):914-21. doi: 10.1046/j.1440-1746.2002.02829.x. J Gastroenterol Hepatol. 2002. PMID: 12164968
-
Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.Acta Neuropathol. 2004 Jul;108(1):43-8. doi: 10.1007/s00401-004-0860-0. Epub 2004 Apr 16. Acta Neuropathol. 2004. PMID: 15088099
-
Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review).Int J Mol Med. 1998 Dec;2(6):715-9. doi: 10.3892/ijmm.2.6.715. Int J Mol Med. 1998. PMID: 9850741 Review.
-
Regulation of cyclooxygenase-2 expression by nitric oxide in cells.Antioxid Redox Signal. 2001 Apr;3(2):231-48. doi: 10.1089/152308601300185197. Antioxid Redox Signal. 2001. PMID: 11396478 Review.
Cited by
-
Effect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo.Oncol Lett. 2012 Jul;4(1):168-174. doi: 10.3892/ol.2012.688. Epub 2012 Apr 23. Oncol Lett. 2012. PMID: 22807982 Free PMC article.
-
Prospects of NSAIDs administration as double-edged agents against endometrial cancer and pathological species of the uterine microbiome.Cancer Biol Ther. 2020 Jun 2;21(6):486-494. doi: 10.1080/15384047.2020.1736483. Epub 2020 Mar 15. Cancer Biol Ther. 2020. PMID: 32174282 Free PMC article. Review.
-
Dietary administration of Nexrutine inhibits rat liver tumorigenesis and induces apoptotic cell death in human hepatocellular carcinoma cells.Toxicol Rep. 2014 Nov 13;2:1-11. doi: 10.1016/j.toxrep.2014.11.006. eCollection 2015. Toxicol Rep. 2014. PMID: 28962332 Free PMC article.
-
Prognostic and Clinical Significance of Cyclooxygenase-2 Overexpression in Endometrial Cancer: A Meta-Analysis.Front Oncol. 2020 Aug 6;10:1202. doi: 10.3389/fonc.2020.01202. eCollection 2020. Front Oncol. 2020. PMID: 32903705 Free PMC article.
-
Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice.Med Oncol. 2010 Mar;27(1):98-104. doi: 10.1007/s12032-009-9179-y. Epub 2009 Feb 24. Med Oncol. 2010. PMID: 19235530
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials